Skip to search formSkip to main contentSkip to account menu

11-dehydro-thromboxane B2

Known as: Thromboxa-5,13-dien-1-oic acid, 9,15-dihydroxy-11-oxo-, (5Z,9alpha,13E,15S)-, 11-keto-thromboxane B2, 11-dehydro-TXB2 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
BACKGROUND Aspirin chemoprophylaxis for coronary artery disease (CAD) is recommended for persons with the metabolic syndrome. We… 
Highly Cited
2004
Highly Cited
2004
Thromboxane (TX) A2, a cyclooxygenase-derived mediator involved in allergic responses, is rapidly converted in vivo to a stable… 
2004
2004
Background and Purpose— Incomplete platelet inhibition by aspirin (aspirin resistance) may be a reason for stroke recurrence in… 
1998
1998
A two-step Phase I study of piroxicam (PXM) and a-difluoromethylornithine (DFMO) alone and in combination was initiated to assess… 
1997
1997
The current analytical methods for the various prostanoids require a separate and extended sample workup, derivatization, and gas… 
Highly Cited
1996
Highly Cited
1996
Nineteen patients with symptoms of chronic venous insufficiency (CVI) were treated with 13-week cycles of intermittent pneumatic… 
1988
1988
The role of thromboxane A2 in sheep endotoxemia, an animal model of the adult respiratory distress syndrome, was investigated by…